Fátima Milhano Santos

Dr. Fátima Milhano Santos

Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2014 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
JMJoão P. Monteiro
João P. Monteiro
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
ARAna S. Rocha
Ana S. Rocha
JCJoão P. Castro‐De‐Sousa
João P. Castro‐De‐Sousa
JQJoão A. Queiroz
João A. Queiroz
Cândida Teixeira TomazCândida Teixeira Tomaz
Cândida Teixeira Tomaz

31 December 2022 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
SCSergio Ciordia
Sergio Ciordia
JMJoana Mesquita
Joana Mesquita
JSJoão Paulo Castro de Sousa
João Paulo Castro de Sousa
APAlberto Paradela
Alberto Paradela
Luis PassarinhaLuis Passarinha
Luis Passarinha

24 March 2024 in Talanta
Verified
Journal Article
Open access
SCSergio Ciordia
Sergio Ciordia
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
JDJoão M.L. Dias
João M.L. Dias
JLJosé Ramón Lamas
José Ramón Lamas
APAlberto Paradela
Alberto Paradela
FCFernando Corrales
Fernando Corrales
Despite technological advances in the proteomics field, sample preparation still represents the main bottleneck in mass spectrometry (MS) analysis. Bead-based protein aggregation techniques have recently emerged as an efficient, reproducible, and high-throughput alternative for protein extraction and digestion. Here, a refined paramagnetic bead-based digestion protocol is described for Opentrons® OT-2 platform (OT-2) as a versatile, reproducible, and affordable alternative for the automatic sample preparation for MS analysis. For this purpose, an artificial neural network (ANN) was applied to maximize the number of peptides without missed cleavages identified in HeLa extract by combining factors such as the quantity (μg) of trypsin/Lys-C and beads (MagReSyn® Amine), % (w/v) SDS, % (v/v) acetonitrile, and time of digestion (h). ANN model predicted the optimal conditions for the digestion of 50 μg of HeLa extract, pointing to the use of 2.5% (w/v) SDS and 300 μg of beads for sample preparation and long-term digestion (16h) with 0.15 μg Lys-C and 2.5 μg trypsin (≈1:17 ratio). Based on the results of the ANN model, the manual protocol was automated in OT-2. The performance of the automatic protocol was evaluated with different sample types, including human plasma, Arabidopsis thaliana leaves, Escherichia coli cells, and mouse tissue cortex, showing great reproducibility and low sample-to-sample variability in all cases. In addition, we tested the performance of this method in the preparation of a challenging biological fluid such as rat bile, a proximal fluid that is rich in bile salts, bilirubin, cholesterol, and fatty acids, among other MS interferents. Compared to other protocols described in the literature for the extraction and digestion of bile proteins, the method described here allowed identify 385 unique proteins, thus contributing to improving the coverage of the bile proteome.

15 July 2014 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
ARAna S. Rocha
Ana S. Rocha
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
JMJoão P. Monteiro
João P. Monteiro
JCJoão P. Castro‐De‐Sousa
João P. Castro‐De‐Sousa
JQJoão A. Queiroz
João A. Queiroz
Luis PassarinhaLuis Passarinha
Luis Passarinha

18 August 2014 in Molecules
Verified
Journal Article
Open access
PDF file
AGAna M. Gonçalves
Ana M. Gonçalves
Augusto Quaresma Henriques PedroAugusto Quaresma Henriques Pedro
Augusto Quaresma Henriques Pedro
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
LMLuís M. Martins
Luís M. Martins
Cláudio MaiaCláudio Maia
Cláudio Maia
Luis PassarinhaLuis Passarinha
Luis Passarinha
The selection of natural and chemical compounds for potential applications in new pharmaceutical formulations constitutes a time-consuming procedure in drug screening. To overcome this issue, new devices called biosensors, have already demonstrated their versatility and capacity for routine clinical diagnosis. Designed to perform analytical analysis for the detection of a particular analyte, biosensors based on the coupling of proteins to amperometric and optical devices have shown the appropriate selectivity, sensibility and accuracy. During the last years, the exponential demand for pharmacokinetic studies in the early phases of drug development, along with the need of lower molecular weight detection, have led to new biosensor structure materials with innovative immobilization strategies. The result has been the development of smaller, more reproducible biosensors with lower detection limits, and with a drastic reduction in the required sample volumes. Therefore in order to describe the main achievements in biosensor fields, the present review has the main aim of summarizing the essential strategies used to generate these specific devices, that can provide, under physiological conditions, a credible molecule profile and assess specific pharmacokinetic parameters.

6 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
JMJoana Mesquita
Joana Mesquita
JCJoão Paulo Castro-De-Sousa
João Paulo Castro-De-Sousa
SCSergio Ciordia
Sergio Ciordia
APAlberto Paradela
Alberto Paradela
Cândida Teixeira TomazCândida Teixeira Tomaz
Cândida Teixeira Tomaz
Oxidative stress is defined as an unbalance between pro-oxidants and antioxidants, as evidenced by an increase in reactive oxygen and reactive nitrogen species production over time. It is important in the pathophysiology of retinal disorders such as diabetic retinopathy, age-related macular degeneration, retinal detachment, and proliferative vitreoretinopathy, which are the focus of this article. Although the human organism’s defense mechanisms correct autoxidation caused by endogenous or exogenous factors, this may be insufficient, causing an imbalance in favor of excessive ROS production or a weakening of the endogenous antioxidant system, resulting in molecular and cellular damage. Furthermore, modern lifestyles and environmental factors contribute to increased chemical exposure and stress induction, resulting in oxidative stress. In this review, we discuss the current information about oxidative stress and the vitreous proteome with a special focus on vitreoretinal diseases. Additionally, we explore therapies using antioxidants in an attempt to rescue the body from oxidation, restore balance, and maximize healthy body function, as well as new investigational therapies that have shown significant therapeutic potential in preclinical studies and clinical trial outcomes, along with their goals and strategic approaches to combat oxidative stress.